| J0897 | Injection, denosumab, 1 mg | 69,600 | $20 | $1.3M |
| J3111 | Injection, romosozumab-aqqg, 1 mg | 65,730 | $10 | $525.9K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 1,950 | $70 | $132.4K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 1,490 | $60 | $88.1K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 450 | $100 | $43.9K |
| 77085 | The provider measures the mineral density of the bones of the axial skeleton and assesses a vertebral fracture. He performs the procedure to assess the patient for the presence of osteoporosis or… | 390 | $50 | $20.8K |
| 77080 | The provider performs an imaging procedure, called dual–energy X–ray absorptiometry (DXA), of one or more bony areas on the trunk to determine the bone mineral density (BMD) and whether the patient… | 420 | $40 | $16.4K |
| 20610 | In this procedure, the provider inserts a needle through the skin of a patient and into a major joint or bursa and then uses the syringe attachment to the needle to remove fluid or he may inject a… | 310 | $50 | $15.9K |
| J7325 | Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | 2,110 | $10 | $14.8K |
| 99203 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the provider… | 200 | $70 | $14.5K |